Anti-PSG9/ PS34/ PSBG-11 monoclonal antibody

Anti-PSG9/ PS34/ PSBG-11 antibody for FACS & in-vivo assay

Target products collectionGo to PSG9/PSG9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1419-Ab-1/ GM-Tg-hg-MP1419-Ab-2Anti-Human PSG9 monoclonal antibodyHuman
GM-Tg-rg-MP1419-Ab-1/ GM-Tg-rg-MP1419-Ab-2Anti-Rat PSG9 monoclonal antibodyRat
GM-Tg-mg-MP1419-Ab-1/ GM-Tg-mg-MP1419-Ab-2Anti-Mouse PSG9 monoclonal antibodyMouse
GM-Tg-cynog-MP1419-Ab-1/ GM-Tg-cynog-MP1419-Ab-2Anti-Cynomolgus/ Rhesus macaque PSG9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1419-Ab-1/ GM-Tg-felg-MP1419-Ab-2Anti-Feline PSG9 monoclonal antibodyFeline
GM-Tg-cang-MP1419-Ab-1/ GM-Tg-cang-MP1419-Ab-2Anti-Canine PSG9 monoclonal antibodyCanine
GM-Tg-bovg-MP1419-Ab-1/ GM-Tg-bovg-MP1419-Ab-2Anti-Bovine PSG9 monoclonal antibodyBovine
GM-Tg-equg-MP1419-Ab-1/ GM-Tg-equg-MP1419-Ab-2Anti-Equine PSG9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1419-Ab-1/ GM-Tg-hg-MP1419-Ab-2; GM-Tg-rg-MP1419-Ab-1/ GM-Tg-rg-MP1419-Ab-2;
GM-Tg-mg-MP1419-Ab-1/ GM-Tg-mg-MP1419-Ab-2; GM-Tg-cynog-MP1419-Ab-1/ GM-Tg-cynog-MP1419-Ab-2;
GM-Tg-felg-MP1419-Ab-1/ GM-Tg-felg-MP1419-Ab-2; GM-Tg-cang-MP1419-Ab-1/ GM-Tg-cang-MP1419-Ab-2;
GM-Tg-bovg-MP1419-Ab-1/ GM-Tg-bovg-MP1419-Ab-2; GM-Tg-equg-MP1419-Ab-1/ GM-Tg-equg-MP1419-Ab-2
Products NameAnti-PSG9 monoclonal antibody
Formatmab
Target NamePSG9
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PSG9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PSG9/ PS34/ PSBG-11 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1419
    Target NamePSG9
    Gene ID5678
    Gene Symbol and SynonymsPS34,PSBG-11,PSBG-9,PSG11,PSG9,PSGII
    Uniprot AccessionQ00887
    Uniprot Entry NamePSG9_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000183668
    Target ClassificationN/A

    The target: PSG9, gene name: PSG9, also named as PS34, PSBG-11, PSBG-9, PSG11, PSGII. The protein encoded by this gene is a member of the pregnancy-specific glycoprotein (PSG) family. This protein family and the closely related carcinoembryonic antigen cell adhesion molecule (CEACAM) gene family are both members of the immunoglobulin superfamily, and are organized as a large gene cluster. This protein is thought to inhibit platelet-fibrinogen interactions. Several studies suggest that reduced serum concentrations of PSGs are associated with fetal growth restrictions, while up-regulation of this gene has been observed in colorectal cancers. Several pseudogenes of this gene are found on chromosome 19. Alternative splicing results in multiple transcript variants that encode multiple protein isoforms. [provided by RefSeq, Sep 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.